| Financial Year |
March 31 2023 |
| Monetary Funds |
3,284,314,035.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
61,157,859.92 |
| Advances to Suppliers |
414,609,707.32 |
| Other Receivables |
255,475,593.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
86,970.00 |
| Inventories |
1,732,141,685.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
396,475,873.19 |
| Total Current Assets |
6,144,174,755.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,943,317.02 |
| Investment Properties |
27,666,125.39 |
| Fixed Assetes |
13,734,722,561.69 |
| Under-construction Projects |
2,029,883,733.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,469,862,180.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
763,416,304.87 |
| Deferred Income Tax Assets |
95,727,007.59 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
25,595,446,430.01 |
| Total Assets |
31,739,621,185.44 |
| Short-Term Loans |
2,221,591,444.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,743,630,206.35 |
| Accounts Received In Advance |
53,143,477.63 |
| Employee Compensation Payable |
248,995,885.27 |
| Taxes Payable |
69,783,619.71 |
| Interest Payable |
-- |
| Dividend Payable |
2,846,864.03 |
| Other payables |
2,831,920,899.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,630,006,198.31 |
| Other Current Liabilities |
1,024,896,718.70 |
| Sub-Total of Current Liabilities |
13,957,924,967.99 |
| Long-term Loans |
5,470,282,646.72 |
| Bonds Payable |
560,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
82,461,979.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,825,577,517.37 |
| Total Liabilities |
20,783,502,485.36 |
| Paid-In Capital(Or Share Stock) |
768,992,731.00 |
| Capital Surplus |
1,448,988,923.88 |
| Surplus Reserve |
1,884,376,724.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,606,374,380.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,956,118,700.08 |
| Owner's Equity（Stockholder's Equity） |
10,956,118,700.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,739,621,185.44 |
